We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aeterna Zentaris Nixes Perifosine Phase III Trial in Multiple Myeloma
Aeterna Zentaris Nixes Perifosine Phase III Trial in Multiple Myeloma
March 12, 2013
Aeterna Zentaris is pulling the plug on a Phase III trial of perifosine in multiple myeloma after a recommendation from its independent data safety monitoring board (DSMB).